These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 15305826)

  • 1. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
    Cole LA; Kohorn EI
    J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test.
    Cole LA; Khanlian SA
    Clin Biochem; 2004 May; 37(5):344-9. PubMed ID: 15087248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
    Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
    J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human chorionic gonadotropin and associated molecules.
    Cole LA
    Expert Rev Mol Diagn; 2009 Jan; 9(1):51-73. PubMed ID: 19099349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2006 Mar; 51(3):217. PubMed ID: 16674021
    [No Abstract]   [Full Text] [Related]  

  • 13. Human chorionic gonadotropin tests.
    Cole LA
    Expert Rev Mol Diagn; 2009 Oct; 9(7):721-47. PubMed ID: 19817556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USA hCG reference service, 10-year report.
    Cole LA; Laidler LL; Muller CY
    Clin Biochem; 2010 Aug; 43(12):1013-22. PubMed ID: 20493830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors.
    Harvey RA; Pursglove HD; Schmid P; Savage PM; Mitchell HD; Seckl MJ
    J Reprod Med; 2008 Aug; 53(8):643-8. PubMed ID: 18773632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quagmire of hCG and hCG testing in gynecologic oncology.
    Muller CY; Cole LA
    Gynecol Oncol; 2009 Mar; 112(3):663-72. PubMed ID: 19007977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.